Baxion
Screening
Tags
Alerts
Theme
Mink Therapeutics, Inc.
INKT
·
NASDAQ
·
$10.44
Share Price as of 11/2
·
$52M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/13/26
10-Q
Q1 ended 03/31/26
05/15/26
10-K
FY 2025
03/31/26
10-Q
Q3 ended 09/30/25
11/14/25
10-Q
Q2 ended 06/30/25
08/14/25
Disclosures
Filter
8-K
Current report
08/13/26
8-K
Current report
06/23/26
8-K
Current report
05/15/26
8-K
Current report
03/31/26
8-K
Current report
03/27/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
08/13/26
S-3/A
Shelf registration (amended)
12/10/25
S-3
Shelf registration
11/07/25
424B5
Prospectus supplement
08/22/25
S-8
Registration of securities for employees
08/14/25
Proxies
Filter
DEF 14A
Definitive proxy
04/30/26
DEF 14A
Definitive proxy
04/30/25
PRE 14A
Preliminary proxy
04/18/25
DEF 14A
Definitive proxy
12/20/24
PRE 14A
Preliminary proxy
12/06/24
Ownership
Filter
Form 4
Insider transaction
10/14/26
144
Proposed sale of securities
10/13/26
Form 4
Insider transaction
09/02/26
Form 4
Insider transaction
09/02/26
Form 4
Insider transaction
09/02/26
Other
Filter
ARS
Annual report to shareholders
04/30/26
EFFECT
Request for effectiveness
12/11/25
CORRESP
Correspondence with the SEC
12/10/25
ARS
Annual report to shareholders
04/30/25
EFFECT
Request for effectiveness
08/16/24
Latest Filings
Filter
10-Q
Q2 ended 06/30/26
08/13/26
8-K
Current report
08/13/26
S-8
Registration of securities for employees
08/13/26
8-K
Current report
06/23/26
10-Q
Q1 ended 03/31/26
05/15/26
Ownership
Filter
Form 4
Insider transaction
10/14/26
144
Proposed sale of securities
10/13/26
Form 4
Insider transaction
09/02/26
Form 4
Insider transaction
09/02/26
Form 4
Insider transaction
09/02/26